The Framingham Study established hypertension as a major cardiovascular risk factor and quantified its atherogenic cardiovascular disease potential. An historical perspective is presented on the epidemiological insights about hypertension derived from 50 years of Framingham Study research into the prevalence, incidence, determinants and hazards of hypertension. Existing misconceptions about the presence of critical levels of blood pressure, the impact of the systolic and diastolic components of blood pressure, the hazard 'mild' hypertension, the impact in advanced age and the hazard of left ventricular hypertrophy. The importance of isolated systolic hypertension and the pulse pressure were demonstrated. It has been demonstrated that hypertension seldom occurs in isolation of other athero-
Introduction
Hypertension is now recognised worldwide as a major clinical and public health problem. However, when the Framingham Study was initiated in 1949 there was great uncertainty about the role of blood pressure in the development of atherosclerotic cardiovascular disease. Before the data emerged from epidemiological investigation of hypertension at the Framingham Study, opinions differed about the value of and indications for the treatment of essential hypertension, the level at which treatment should be considered, or the age at which therapy should be instituted. There was no sound basis for selecting those hypertensive persons most likely to develop cardiovascular disease. The common variety of hypertension was labelled 'benign essential hypertension' implying that it was not particularly hazardous and might even be a normal or beneficial condition in older persons. The rise in blood pressure with advancing age was considered necessary in order to ensure adequate tissue perfusion as the arterial circulation progressively narrowed. Because the average pressure tended to increase with age normal pressures for the elderly were designated at higher values than those for younger adults. Hence, Correspondence: WB Kannel genic risk factors, with which it tends to cluster. This clustering with other metabolically linked risk factors has been shown to reflect insulin resistance promoted by weight gain and abdominal obesity. Obesity was shown to be one of the major determinants of hypertension in the general population. Left ventricular hypertrophy was shown to be an ominous harbinger of cardiovascular disease rather than an incidental compensatory phenomenon. Multivariate risk profiles for coronary disease, stroke, peripheral artery disease and heart failure have been devised to facilitate incorporation of elevated blood pressure in a global, multivariate cardiovascular risk assessment.
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a 'normal' pressure was designated to be 100 mm Hg plus the age of the patient. It was also widely held that women tolerated hypertension well.
At the time the Study was initiated, and to some degree still tenaciously held by many physicians today, it was the prevalent concept that the diastolic component of the blood pressure is chiefly responsible for the cardiovascular sequelae of hypertension. 1 Isolated systolic hypertension was considered an innocuous accompaniment of arterial stiffening. There was also the notion that only a fixed 'basal' blood pressure elevation was important and the lowest pressure recorded on the patient (often under sedation at bed rest) was used to determine the need for treatment. Left ventricular hypertrophy, a common feature of long-standing hypertension, was regarded as an incidental compensatory phenomenon.
For many years there was a debate as to whether 'hypertension' was a discrete disease to be distinguished from elevated blood pressure. 2 It was felt by many that there was some critical value of blood pressure where normal leaves off and hypertension begins.
Medical trivia
Although there was agreement about the necessity for the early detection and treatment of overt athero-Journal of Human Hypertension sclerotic cardiovascular disease (which was not considered preventable) there was skepticism about the need to detect and treat asymptomatic abnormalities such as elevated blood pressure and blood lipids. 3 There were some who doubted the validity of the epidemiological approach and the risk factor concept. 3 The perception prevailed that it was meddlesome to label, alarm and treat persons with these asymptomatic conditions, particularly when they were within the usual range of values found in the apparently healthy population. However, Framingham Study investigation of the way cardiovascular disease develops in the general population indicated that much of the premature cardiovascular mortality occurs with little warning in populations generally prone to atherosclerosis and in relation to identifiable risk factors present well in advance of symptoms. 4 It was determined that a preventive approach is essential because more than half of the coronary deaths occurred suddenly and unexpectedly outside the hospital and only 20% of myocardial infarctions were preceded by angina and most strokes were unheralded by transient ischaemic attacks. 4, 5 It was evident that atherosclerotic cardiovascular events must be dealt with in evolution if substantial inroads are to be made against the epidemic. One of the most common and powerful modifiable predisposing risk factors that needed attention was hypertension.
Components of blood pressure
Clinical decisions and controlled trials for too long emphasized the diastolic pressure. Epidemiological investigation at the Framingham Study found nothing to suggest a greater impact of the diastolic than systolic pressure on the occurrence of cardiovascular disease. The preference for the diastolic component of the blood pressure as the more important promoter of the adverse sequelae of hypertension may derive from the proclamation about hypertension in the 1927 edition of the classic Cecil's medical textbook that: 'The blood pressure is found to be distinctly raised; systolic pressures of 250 mm Hg are quite common. More important than the systolic pressure is the increase in the diastolic pressure, for it has been shown that as the diastolic pressure increases, the arteries lose their normal elasticity and efficiency and greater work is consequently thrown upon the heart. It is therefore important to bear in mind, in determining the prognosis, that those individuals whose diastolic blood pressures remain relatively low, in spite of high systolic pressures, are decidedly less apt to suffer cardiac decompensation and cerebral apoplexy.' 6 This concept of the greater importance of the diastolic pressure was reinforced by the first JNC report in 1977 that continued to recommend the diastolic pressure as the basis for diagnosis and treatment of hypertension.
7 It was further reinforced by the use of diastolic pressure as the basis for therapeutic interventions in hypertension clinical trials. The earliest indication that the systolic pressure was more strongly related to mortality than diastolic pressure came from the insurance industry. 8, 9 They also challenged the concept that normal systolic pressure was 100 mm Hg plus the subject's age. An investigation of London busmen soon after also concluded that systolic pressure was a better predictor of hypertensive events following coronary disease. 10 In 1969 the Framingham Study disputed the accepted notion that the adverse consequences of hypertension derive chiefly from the diastolic pressure for coronary disease and a year later for stroke. 11, 12 Several years later these findings of an equal or greater influence of systolic pressure were extended to peripheral artery disease and heart failure. 13 The Framingham Study showed that in persons whose diastolic pressures did not exceed 95 mm Hg, cardiovascular disease risk increased progressively with the systolic pressure at all ages in both men and women (Figure 1 ). 14 The common clinical practice of relying on the diastolic pressure to judge the need for treatment in persons with an elevated systolic blood pressure was shown to be invalid. In this circumstance, knowledge of the diastolic pressure was found to be misleading in evaluating the cardiovascular risk. 14 The incidence of all the cardiovascular sequelae of hypertension were shown to be greater for isolated systolic than isolated diastolic blood pressure elevations. Each standard deviation increase in systolic blood pressure increased the propensity to cardiovascular disease 40-50%, whereas for diastolic pressure, the increment was 30-35%. Following the Framingham Study many other population-based investigations, in a variety of population samples, confirmed that systolic pressure exerts a stronger influence than diastolic pressure. 1 Data from clinical trials also indicated that greater reliance should be placed on systolic pressure in evaluating hypertensive risk and control. 15, 16 However, despite all the evidence, trials of hypertension treatment continued to use diastolic pressure as entry and outcome criteria until the recent SHEP and Syst-Eur studies. 15, 16 These studies demonstrated the benefits of lowering systolic blood pressure elevations in the elderly to reduce the risk of stroke and myocardial infarction. It was only after these trials that practitioners have begun to relinquish their overemphasis on the diastolic pressure in their evaluation and treatment of hypertension.
Arterial compliance
The foregoing epidemiological facts and clinical trials have fostered new concepts questioning the view that elevated peripheral resistance is the underlying cause of hypertension and that the best indicator of hypertension is the diastolic blood pressure. Because mean arterial pressure is closer to diastolic than systolic pressure the former was used as a surrogate for the mean arterial pressure and elevated diastolic pressure became the hallmark of hypertension. 17 The notion that the increase in systolic pressure with age was innocuous persisted until the SHEP and Syst-Eur studies reported their results, despite the Framingham Study data challenging this for many years.
Aging is the most important cause of arterial stiff- ness, but hypertension accelerates this aging process by increasing the stretching of the artery rendering it stiffer. 17 Increased aortic stiffness increases aortic pulse pressure for any given stroke volume and raises the peak pressure in the central arteries and left ventricle predisposing to left ventricular hypertrophy and failure and reduces the diastolic pressure predisposing to myocardial ischaemia by reducing coronary perfusion which occurs during diastole. 17, 18 The Framingham Study confirmed conclusively that the mean arterial blood pressure increases only slightly throughout adult life 19 and showed that a marked reduction in diastolic pressure occurs beyond age 50, accompanied by a conJournal of Human Hypertension tinuing rise in systolic pressure so that the pulse pressure increases dramatically in later life. Systolic and pulse pressure have been shown to be of greater predictive value than diastolic pressure in the Framingham Study. 20 The Framingham Study established by 1980 that there is a more robust relationship between cardiovascular disease and systolic than diastolic pressure. Indeed, recent Framingham Study reports show that for any given systolic pressure cardiovascular events are inversely related to diastolic pressure. 20 Risk of cardiovascular events in the Framingham Study has been shown to be related to pulse pressure at any level of blood pressure ( hypertension has been shown to carry a substantial risk for development of cardiovascular morbidity and mortality. 21, 22 These epidemiological findings support the contention that large artery stiffness is an important feature of hypertensive cardiovascular disease. Thus, in studies of hypertension, recent attention is being focused on arterial stiffness as a causal factor and target of therapy, diverting attention away from peripheral resistance as the hallmark of the disease. This arterial stiffness is usually manifested as an increased pulse pressure and isolated systolic hypertension.
Blood pressure or hypertension
Before epidemiological research, 'hypertension' was considered more as a disease than as a risk factor. There was the perception that there was a critical blood pressure value that distinguished hypertensive persons from those who did not have the disease. This would require that there be a bimodal distribution of blood pressure in the general population, which has never been convincingly demonstrated. Also, the distributions of blood pressure in those with and without cardiovascular disease overlap to such a degree that no blood pressure can distinguish cases from non-cases. Investigation of the blood pressure relationship to development of cardiovascular disease revealed a continuous graded influence extending down into the level of pressures considered 'normal'.
It has been claimed that there is an excess risk of mortality at both high and low levels of diastolic blood pressure. Some have claimed that this applies only to persons with coronary disease whereas others claim it applies in general. 23, 24 The Framingham Study examined the hypothesis of a J-curve relation between diastolic blood pressure and coronary mortality and found it confined to persons with a myocardial infarction. 25 Thus it appears that there is a continuous graded influence of blood pressure on coronary morbidity and mortality in healthy persons with no critical value where 'normal' leaves off and 'hypertension' ensues. It appears that it is blood pressure that kills and not 'hypertension'.
Basal or casual pressure
At the initiation of the Framingham Study it was considered appropriate to ignore labile and casual blood pressure elevations. 26 Clinicians tended to disregard casual office blood pressures and rely on 'basal' pressures obtained after a period of bed rest under sedation to establish the presence of 'hypertension' requiring treatment. 26, 27 Epidemiological investigation at Framingham revealed that an average of a series of pressures provided a valid estimate of the risk regardless of how labile it was. 28 Attempt to improve the estimate of risk by using the lowest of three recorded blood pressures proved disappointing. This refuted the common clinical practice of using the lowest blood pressure recorded as the index of the hypertensive hazard. The average of a series of pressures appeared to be the best indicator of the cardiovascular risk.
Cardiovascular hazards
Epidemiological research demonstrated that because of its high prevalence in the general population and sizeable risk ratio, hypertension is a powerful risk factor for cardiovascular disease accounting for 29 Hypertension was shown to predispose powerfully to all of the major atherosclerotic cardiovascular events including coronary disease, stroke, peripheral artery disease and heart failure. 29, 30 Risk ratios were shown to be larger for stroke and heart failure as clinical studies suggested, but the Framingham Study data indicated that coronary disease was in fact the most common and most lethal sequela, equalling in incidence all the other cardiovascular disease outcomes combined ( Table 2 ). The less than expected efficacy of antihypertensive therapy for avoiding coronary disease led some to doubt whether there was a direct causal relationship between hypertension and coronary disease. However, the epidemiological data indicated that the incidence of every clinical manifestation of coronary disease, including angina, myocardial infarction, and sudden death increased in proportion to the severity of the antecedent hypertension. 31 In contrast to blood pressures measured before myocardial infarctions, the blood pressure measured after the event was found to be unrelated to survival over the next 5 years. 32 However, the blood pressure measured prior to the infarction was related to survival after infarction with hypertensive persons having almost three times the mortality of previously normotensive infarct patients. These puzzling findings were explained by the two-fold greater risk of death in hypertensive patients who experienced a spontaneous substantial decrease in their pressure after their myocardial infarction compared to that of those who remained hypertensive. A decrease in pressure with interim myocardial infarction was found to occur frequently and must be taken into account in evaluating hypertensive risk after a myocardial infarction.
The Framingham Study revealed that approximately 30% of the myocardial infarctions that occur in the general population go unrecognised. For reasons that are unclear, it was found that like diabetics, hypertensive persons were unusually susceptible to these unrecognised infarctions (Table 3) . This hypertensive propensity to unrecognised infarctions was found to persist even excluding persons with possible confounders such as diabetes, 
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ECG-LVH, and antihypertensive treatment. 33 In male hypertensives about 35% of infarctions went unrecognised-double the rate of normotensive men and in hypertensive women close to half the infarctions were unrecognised. These observations led to the recommendation that hypertensive persons should be periodically ECG monitored for the occurrence of a silent myocardial infarction.
It was widely believed that mild hypertension promotes brain infarctions, whereas severe hypertension leads to intracerebral haemorrhage. Investigation of the relation of hypertension to the occurrence of strokes in the Framingham Study indicated that the preponderance of hypertension-related strokes in the Framingham Study were atherthrombotic brain infarctions, whether the hypertension was severe (70%) or mild (56%). The proportion of strokes due to intracerebral haemorrhage in mild hypertension (5%) was virtually identical to that for severe hypertension (4%). Furthermore, the proportion of strokes due to brain infarction increased at the expense of subarachnoid haemorrhage and cerebral embolus, whereas the proportion due to intracerebral haemorrhage did not change.
Hypertension is recognised as a major precursor of heart failure but some have assigned a more dominant role to coronary disease. Investigation of the role of hypertension in heart failure in the Framingham Study revealed that adjusting for age and other relevant risk factors, hypertension imposed a two-fold increased risk in men and increased the hazard three-fold in women. Hypertension was found to account for 39% of the cases in men and 59% in women. Survival following onset of hypertensive heart failure was bleak with only 24% of men and 31% of women surviving 5 years. 34 Thus hypertension was the most common predisposing factor for heart failure, contributing a large proportion of the cases in the general population (Table 4) . It is likely that earlier and more aggressive blood pressure control offer the greatest promise for reducing the incidence of heart failure and its associated mortality.

Left ventricular hypertrophy
Left ventricular hypertrophy is a response of the heart to the chronic pressure overload imposed by hypertension. The electrocardiographic pattern of increased R-wave voltage, and ST and T-wave repolarisation abnormalities was well recognised as an important clinical diagnostic entity. However, before epidemiological investigation of this entity in the Framingham Study in 1969 there were no prospective precise estimates of its prevalence, incidence, and prognosis in the general population. 35 Before this it was believed that the hypertrophy was a compensatory phenomenon in response to the increased workload imposed by the hypertension. There was even fear that reversal of this hypertrophy would be detrimental to cardiac function.
Epidemiological investigation at the Framingham Study revealed that left ventricular hypertrophy, rather than an asset in hypertension, was an ominous harbinger of disabling and lethal cardiovascular events. 35, 36 When it occurred, it was found to be associated with a marked increase in the risk of coronary disease, stroke, and heart failure. The risk of cardiovascular sequelae of hypertension was shown to increase with the severity of the hypertrophy whether evaluated by ECG, echocardiogram, or chest film. 37, 38 No critical amounts of hypertrophy have been found that delineate compensatory from pathological hypertrophy. Risk of cardiovascular sequelae was shown to increase progressively with the increase in echocardiographically measured left ventricular mass, and severity of ECG manifestations of the condition. 37, 38 Each 50 g/m increment in left ventricular mass was associated with a 50% greater risk of developing cardiovascular disease and nearly twice the risk of a cardiovascular disease death. It has been shown that antihypertensive therapy can regress left ventricular hypertrophy in hypertensive persons, but it is not established whether such regression reduces the associated high risk of cardiovascular events. Investigation of the prognostic implications of reversal of ECG indications of left ventricular hypertrophy in the Framingham Study cohort indicated that improvement in the ECG features of left ventricular hypertrophy was associated with a substantial reduction in the risk of cardiovascular events. 38 These results strongly suggest that regression of left ventricular hypertrophy by antihypertensive therapy may well reduce the risk of cardiovascular events.
The Framingham Study showed that left ventricular hypertrophy is an important feature of the evolution of hypertension on to heart failure. Cardiovascular risk ratios for hypertensive persons who developed left ventricular hypertrophy were found to be greatest for cardiac failure but coronary disease was shown to be the most common lethal hazard.
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Heart rate
In 1975 four Chicago epidemiological surveys indicated a strong correlation between the heart rate and blood pressure. 40 As early as 1945 it was shown in a group of US army officers that elevation of the heart rate is followed by an increase in blood pressure and development of hypertension. 41 The Framingham Study in 1987 confirmed this and showed that the predictive power of the heart rate rivalled that of obesity. 42 The Framingham Study in 1987 showed the heart rate to be related to the rate of development of cardiovascular and all-cause mortality in men, even taking into account other risk factors. 43 The relationship to sudden coronary fatalities was particularly strong with a linear increase with the heart rate. In the Framingham Study the association of the heart rate with cardiovascular mortality was also observed in the hypertensive segment of the population. 44 Heart rate has been shown to be a marker of increased sympathetic tone by Julius and Palatini. 45 High heart rates are also found in persons with features of the insulin resistance syndrome. A large proportion of hypertensive persons has increased sympathetic activity, tachycardia, and the metabolic syndrome. The implications for treatment of hypertension is to select a therapy that not only reduces the blood pressure but also decreases the heart rate and improves the metabolic abnormalities associated with insulin resistance. The efficacy of so doing needs to be tested by randomised trials.
The elderly and women
Before epidemiological insights were provided by the Framingham Study hypertension was considered to be less dangerous in the elderly and women. Because blood pressures tended to increase with age higher pressures were accepted as more normal in the elderly than in the middle-aged. 30 Epidemiological data from the Framingham Study has corrected this misconception by demonstrating that hypertension risk ratios do not diminish greatly with advancing age and that the hazard of a given elevation of blood pressure in the elderly is actually higher than the same pressure in middle-age. 30 The Framingham Study also showed that although women have a lower incidence of cardiovascular events than men do at the same blood pressure, the risk ratio is just as large in women (Table 5) .
Concomitant risk factors
A tendency for other risk factors to cluster with hypertension was long noted in the Framingham Study. 46 Many of the risk factors that tend to cluster with elevated blood pressure were shown to predict its occurrence and greatly influence its impact on the occurrence of atherosclerotic cardiovascular disease. 46, 47 The Framingham Study determined the prevalence of occurrence of one or more risk factors in association with elevated blood pressure and compared this with the rate of clustering expected by chance. 48 We also examined the influence of weight and weight gain on the tendency for risk factors to cluster in hypertensive persons. Clusters of three or more of the metabolically linked risk factors (elevated cholesterol, triglyceride, glucose, and body mass index and reduced HDL-cholesterol) occurred at 4 -5 times the rate expected by chance in men and women respectively. Only 22% of men and 18% of women had elevated blood pressure in isolation with other risk factors. The tendency for risk factors to cluster in persons with hypertension was shown to increase stepwise with weight gain. A 5-lb weight gain imposed a 30% increase in the extent of clustering.
Risk of coronary disease in persons with elevated blood pressure was shown to vary widely in relation to the amount of risk factor clustering. Among persons with elevated blood pressure, it was estimated that 63% of coronary events in men and 78% in women occur in conjunction with two or more risk factors and 39% of the coronary events in hypertensive men are attributable to clustering of two or more other risk factors. In women, 68% of coronary events are attributable to the presence of two or more accompanying risk factors (Table 6 ). The Framingham Study has long suggested that hypertension is best regarded as a component of metabolic syndrome and cardiovascular risk profile. [46] [47] [48] To assist in risk stratification of hypertension, multivariate risk formulations have been contrived to make it convenient for physicians to quantify the cardiovascular hazards faced by their hypertensive patients. 49 
Summary
Before data emerged from the epidemiological investigation of hypertension by the Framingham Study, most hypertension was considered a benign condition. At the initiation of the Framingham Study
Journal of Human Hypertension it was considered appropriate to ignore labile and systolic elevations of blood pressure. Clinicians tended to disregard office blood pressure elevations in favour of 'basal' pressures. Isolated systolic hypertension was rarely taken seriously before epidemiological evidence to the contrary was provided. Hypertension was considered less dangerous in the elderly and women and because blood pressure tended to increase with age, higher pressures were accepted as normal in the elderly. Left ventricular hypertrophy was considered an incidental compensatory phenomenon. Hypertension was not recognised as an ingredient of a cardiovascular risk that tended to cluster with other metabolically linked risk factors. It is clear that accepted teachings that were based on case studies and clinical impression have not stood the test of prospective epidemiological investigation. Physicians have corrected many misconceptions about hypertension because of epidemiological insights provided by the Framingham Study.
